Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

Hemangioma Associated With High Rates of Morbidity

Lead Sponsor:

Medical College of Wisconsin

Collaborating Sponsors:

University of California, San Francisco

Columbia University

Conditions:

Hemangioma

Eligibility:

All Genders

Up to 18 years

Phase:

NA

Brief Summary

We are conducting a study on the possible presence of PHACES in children with large facial hemangiomas and lumbosacral hemangiomas of infancy (hemangioma in the lower back) . With this study we hope t...

Detailed Description

Large hemangiomas of the face can be associated with anomalies of the blood vessels of head and chest. The acronym PHACES indicates the association of Posterior fossa and other brain malformations, fa...

Eligibility Criteria

Inclusion

  • Segmental Facial Hemangioma
  • Inclusion criteria:
  • Infants less than 1 year of age
  • Hemangiomas of the head /facial area measuring 22cm2 or greater.
  • Exclusion criteria:
  • Children greater than 1 year of age.
  • Children with segmental hemangiomas present in locations other than the head.
  • Children presenting with localized (focal) or indeterminate hemangiomas in any location.
  • Children with other vascular tumors (such as tufted angioma, Kaposiform hemangioendothelioma, non-involuting congenital hemangioma or rapidly-involuting congenital hemangioma) or vascular malformations.
  • Lumbosacral Hemangioma
  • Inclusion criteria:
  • Individuals less than 18 years of age.
  • Hemangioma, hemangioma precursor, or definitive residual hemangioma larger then 2.5 cm in diameter, overlying the midline lumbar spine or sacral spine in which any portion of the hemangioma is located over the midline.
  • Exclusion Criteria:
  • Excluding perirectal hemangiomas that do not extend onto the sacral spine.
  • Excluding perineal hemangiomas that do extend to overlay the sacral spine.

Exclusion

    Key Trial Info

    Start Date :

    November 1 2005

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2010

    Estimated Enrollment :

    433 Patients enrolled

    Trial Details

    Trial ID

    NCT00394888

    Start Date

    November 1 2005

    End Date

    January 1 2010

    Last Update

    September 20 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Beth Drolet, MD

    Milwaukee, Wisconsin, United States, 53226